News

February 07, 2023


New upcoming LIVE Webinar: Expanding AI Capabilities in Digital Health with Hexoskin

Hexoskin Webinar - Replay Edition - Expanding AI Capabilities in Digital Health with Hexoskin

We just added online our webinar on Expanding AI Capabilities in Digital Health with Hexoskin.

The implementation of digital health technologies has been recently accelerated with the global pandemic and transition to remote work.

As a result, more researchers, clinicians, and industry leaders are utilizing platforms like Hexoskin to continuously collect remote health data and develop machine learning models.

The Hexoskin body sensors are a unique ambulatory heart monitor with breath sensors for health monitoring, making Hexoskin an interesting healthcare wearable.

Listen to our guest speakers to learn more about how the Hexoskin Connected Health Platform is leading the AI revolution in digital health technologies to improve health across patient populations, organizations, and industries.

You can watch the webinar on our Hexoskin YouTube Channel.

Ready to Discuss Your Next Project with Hexoskin?

Contact our team to discuss how Hexoskin can support you.

Astroskin featured in Limitless With Chris Hemsworth on Disney+

What if you could combat aging and discover the full potential of the human body? Global movie star Chris Hemsworth (“Extraction,” “Thor,” “The Avengers”) explores this revolutionary idea in the new National Geographic original series “Limitless with Chris Hemsworth” created by Darren Aronofsky and hailing from his production company Protozoa and Jane Root’s Nutopia.

New scientific research is shattering conventional wisdom about the human body and offers fascinating insights into how we can all unlock our body’s superpowers to fight illness, perform better and even reverse the aging process. This science is put to the test by Hemsworth, who, despite being in peak superhero condition, is on a personal mission to learn how to extend our health, strength and intellect further into our later years.

Undergoing a series of epic trials and extraordinary challenges in order to understand the limits of the human body, he’ll learn firsthand how we can live better for longer by discovering ways to regenerate damage, maximize strength, build resilience, supercharge memory, and confront mortality. 

The Astroskin Vital Signs Monitoring Platform, an advanced wearable health monitoring system, is used in the first episode of the series titled Stress-Proof now streaming on Disney +.

Ever since his teenage years, stress has been part of Chris’ life, and he wants to learn how to deal with it better. In this episode of the series, Chris Hemsworth will learn powerful physical and psychological techniques that can be used to control the stress in our lives and combat the risk it poses to long-term health.

Astroskin worn by actor Chris Hemsworth in National Geographic Series Limitless with Chris Hemsworth on Disney+ Episode 1 - Stress ProofThe actor takes on the challenge to stay calm during a terrifying walk along a crane that’s projecting out from the roof of a skyscraper. We follow him practicing his walk in VR. Chris is supported during his training by Dr. Modupe Akinola who interprets the actor's physiological response measured with the Astroskin.

Chris Hemsworth - Episode 1 - Stress Proof - Disney Plus - National Geographic - Nutopia -Training Walk on a Crane with VR and AstroskinDuring the episode, we also follow Chris Hemsworth wearing the Astroskin during the chilling walk on the crane at the top of a 900-foot-tall skyscraper.

Chris Hemsworth's perspective of looking down from the Crown Towers Crane While Wearing Astroskin

Limitless with Chris Hemsworth is streaming on Disney+. 

February 07, 2023

Connected Health › COVID-19 ›


Hexoskin to Support Medical Research and Covid-19 Response

Hexoskin has been working with governements and health systems in the US and Canada to define actions to support healthcare services during the COVID-19 response.

We are currently putting in place patient monitoring programs in hospitals and at home for COVID-19 patients. These projects are important to support telehealth services, but also to gather data for medical research and manage the public response to the virus. We are now working on onboarding our first COVID-19 patients.

The data collected will also be used to develop AI/machine learning software to better assess the risk of COVID-19 patients recovering at home. Hexoskin biometric shirts can continuously measure respiration effort in addition to cardiac activity, which provides unique data to understand the evolution of the disease and its effects on lung function.

We are also working with health systems on rapidly setting up programs to ensure the continuity of care for patients currently enrolled in cardiac and pulmonary rehabilitation programs with online tools.

We understand that hospitals are currently focused 100% on hospitalized patients, that's why Hexoskin is setting up telehealth teams of its own and offering these resources to support these programs and complement health systems' resources.

If you are looking for help for telehealth programs or COVID-19 home monitoring programs please contact us today: contact@hexoskin.com / 1-888-887-2044

 

Hexoskin at Biosensors for Medical Wearables in Boston: Overcoming Challenges in Long-Term Medical Monitoring

Hexoskin's co-founder and CEO Pierre-Alexandre Fournier has been invited to talk about long-term vital signs monitoring at the Biosensors for Medical Wearables Conference in Boston on October 25th.

Vital signs sensors traditionally used for cardiac and respiratory monitoring involve adhesives or tape to keep the sensors in place on the skin. Experience has shown there's a tradeoff between monitoring duration (1 to 14 days), and adhesive agressiveness, which can lead to skin rashes or wounds.

There's now a safer and more convenient way for patients to record long-term vital signs data needed for diagnosis or to guide care or rehabilitation: smart textiles. Hexoskin users have successfully demonstrated the advantages of using a form factor that patients like. Researchers have documented it in over 200 scientific papers.

In his talk, Fournier will describe medical applications of smart textile sensors for patients with cardiac and respiratory diseases, as well as opportunities in research in mental health and rare diseases. He will also share unique insights into Hexoskin's experience in space medicine research aboard the International Space Station.

Please reach out for more information: contact@hexoskin.com

October 07, 2022


Hexoskin at the 24th SoCalBio Annual Conference in Long Beach: Enabling a Distributed Healthcare Regime

Hexoskin's co-founder and CEO Pierre-Alexandre Fournier has been invited to talk about the adoption drivers for distributed healthcare at the SoCalBio 24th annual conference in Long Beach October 6-7.

We now have the technology to deploy connected health solutions to improve healthcare access at home and close to home. What is slowing down adoption? We still need better financial incentives, provider education, a regulatory environment for connected health and home care adapted to this new care setting, and leadership from providers and payors, among other things.

The panel "Enabling a Distributed Healthcare Regime:" Precision Medicine in Homecare Through Remote, Medical Grade Monitoring with Wearables and Other Smart Devices will be moderated by William Dolphin, PhD.

Moderator:

  • William Dolphin, PhD, President, William Dolphin Consulting

Panelists:

  • Ruey-Kang Chang, MD, MPH, CEO, QT Medical, Inc.
  • Pierre-Alexandre Fournier, Co-founder & CEO, Hexoskin
  • Ronald J. Buschur, President & CEO, Advanced Medical Device Technologies Inc

Hexoskin has a long history of research collaborations in Southern California. Institutions such as the Naval Health Research Center, University of California in San Diego, California State University, and the Children's Hospital of Los Angeles have published many papers using the Hexoskin connected health platform to collect physiological data about participants.

September 07, 2022


Hexoskin at the International Space Convention 2022

Hexoskin's co-founder and CEO Pierre-Alexandre Fournier is going to talk at the International Space Convention 2022 on September 9th, hosted in Bursa, Turkey.

His presentation entitled "Medical Research in Microgravity: Challenges for Future Long-Term Space Missions and the Moon" will discuss current themes for medical research in space and challenges we need to address for future long-term missions to the Moon and beyond.

Hexoskin has been involved in space medicine since 2011, and the Astroskin wearable vital signs sensor system is used for clinical trials aboard the International Space Station since 2019.

In July 2022 Hexoskin has received the International Space Station Research Innovation Award for Human Health in Space from the American Astronautical Society. 

 

International Space Convention 2022 - Astroskin and space medicine

 

About Astroskin

Astroskin is the most advanced ambulatory vital signs monitoring platform for medical research in the world. Developed to qualify for space research, it can now benefit the most innovative research in Space and on Earth.

Astroskin offers state-of-the-art continuous real-time monitoring for 48 hours of blood pressure, pulse oximetry, 3-lead ECG, respiration, skin temperature, and activity.

The Astroskin garments are now available in a wide range of sizes for men & women. A large number of research organizations already use the Astroskin vital signs monitoring platform to collect data to answer their research questions.

September 07, 2022

Astroskin ›


Join Us for a new Astroskin LIVE Event!

Astroskin LIVE Demo

Join us for our new Astroskin LIVE Demo on September 21, 2022, at 11:00 a.m. EDT. Our team will perform a complete demo of the industry-leading Astroskin Vital Signs Monitoring Platform.

Our LIVE Demo events are good opportunities to meet the Hexoskin team and learn more about everything related to our solutions for remote health monitoring.

Whether you are new to Astroskin or need a refresh on the Astroskin platform, our Astroskin Live Demo will provide a deep look at the Astroskin features, including new functionalities.

Join Us For a New Hexoskin LIVE Demo!

Hexoskin LIVE DemoJoin us for our new Hexoskin LIVE Demo on September 7, 2022, at 11:00 a.m. EDT. 

Our LIVE Demo events are good opportunities to meet our team and learn more about everything related to our solutions for remote health monitoring.

Whether you are new to Hexoskin or need a refresh on the Hexoskin platform, our Hexoskin Live Demo will provide a deep look at the Hexoskin features, including new functionalities.

August 19, 2022


Hexoskin CEO Invited to Speak at the HITLAB Digital Health Symposium

Hexoskin CEO Speaker at HITLAB Digital Health Symposium

Pierre-Alexandre Fournier, Hexoskin CEO & Cofounder, will speak at the HITLAB Digital Health Symposium on August 25, 2022. M. Fournier will present an overview of the work conducted by the Hexoskin Community on digital health research and projects with the Hexoskin & Astroskin platforms.

The theme is "Bridging the Information/Data Gap". Health is complex and information to evaluate patients is often not available when they are not in a clinical setting. We've made our mission at Hexoskin to allow researchers and professionals to collect health data in places they couldn't before, from homes and workplaces to the International Space Station!

The Hexoskin community has published over 160 papers so far, on subjects that include cardiac and respiratory health, aging, rare diseases, psychiatry, and healthcare workers health and safety. We collect most of them on this page

August Symposium: Bridging the Information / Data Gap image

 

Hexoskin Receives 2022 International Space Station Research Innovation Award for Human Health in Space from American Astronautical Society

Hexoskin - International Space Station Research Innovation Award for Human Health in Space 2022

 Washington, D.C. - July 28th, 2022

The American Astronautical Society has awarded today the 2022 International Space Station Research Innovation Award for Human Health in Space to Hexoskin (Carré Technologies Inc.) for demonstrating a comprehensive physiology monitoring system for use in research and in situ crew care.

The Astroskin Bio-Monitor System was launched with SpaceX mission CRS-16 in December 2018 and was commissioned by Canadian astronaut David Saint-Jacques in January 2019. It is currently used in two clinical trials in microgravity to improve our understanding of cardiovascular health in space and physiological models of aging. These studies will help support human health during long-term space missions beyond Earth's orbit: to the Moon, Mars, and beyond.

"This award celebrates 10 years of collaboration between Hexoskin and space agencies, and a technology that has a real impact on medical research in space and in our communities" said Pierre-Alexandre Fournier, CEO and co-founder of Hexoskin.

The Hexoskin space medicine team supports the operations of the Astroskin Bio-Monitor in space with the collaboration of the Canadian Space Agency, NASA, and other space agencies and subcontractors.

About Astroskin

Astroskin is the most advanced ambulatory vital signs monitoring platform for medical research in the world. Developed to qualify for space research, it can now benefit the most innovative research in Space and on Earth.

Astroskin offers state-of-the-art continuous real-time monitoring for 48 hours of blood pressure, pulse oximetry, 3-lead ECG, respiration, skin temperature, and activity.

The Astroskin garments are now available in a wide range of sizes for men & women. A large number of research organizations already use the Astroskin vital signs monitoring platform to collect data to answer their research questions.

About the ISS R&D Conference

The International Space Station Research and Development Conference (ISSRDC) brings together leaders from the commercial sector, U.S. government agencies, and academic communities to foster innovation and discovery onboard the International Space Station (ISS).

The conference is hosted by the Center for the Advancement of Science in Space, Inc., manager of the ISS National Laboratory; NASA; and the American Astronautical Society (AAS). ISSRDC showcases how the space station continues to provide a valuable platform for research and technology development that benefits humanity and enables a robust and sustainable market in low Earth orbit. Additionally, the ISSRDC marketplace expo allows companies to showcase how they are advancing opportunities in low Earth orbit and provides a venue to meet with researchers, stakeholders, and policymakers.

About the American Astronautical Society

The American Astronautical Society (AAS), established in 1899, is a major international organization of professional astronomers, astronomy educators, and amateur astronomers. Its membership of approximately 8,000 also includes physicists, geologists, engineers, and others whose interests lie within the broad spectrum of subjects now comprising the astronautical sciences.

The mission of the AAS is to enhance and share humanity’s scientific understanding of the universe as a diverse and inclusive astronautical community, which it achieves through publishing, meetings, science advocacy, education and outreach, and training and professional development.